title: Grading dermatologic adverse events of cancer treatments: the Common Terminology Criteria for Adverse Events Version 4.0.
abstract: Dermatologic adverse events to cancer therapies have become more prevalent and may to lead to dose modifications or discontinuation of life-saving or prolonging treatments. This has resulted in a new collaboration between oncologists and dermatologists, which requires accurate cataloging and grading of side effects. The Common Terminology Criteria for Adverse Events Version 4.0 is a descriptive terminology and grading system that can be used for uniform reporting of adverse events. A proper understanding of this standardized classification system is essential for dermatologists to properly communicate with all physicians caring for patients with cancer.
authors.affiliation: Medical Oncology Clinical Research Unit, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
authors.forename: Alice P
authors.initials: AP
authors.lastname: Chen
authors.forename: Ann
authors.initials: A
authors.lastname: Setser
authors.forename: Milan J
authors.initials: MJ
authors.lastname: Anadkat
authors.forename: Jonathan
authors.initials: J
authors.lastname: Cotliar
authors.forename: Elise A
authors.initials: EA
authors.lastname: Olsen
authors.forename: Benjamin C
authors.initials: BC
authors.lastname: Garden
authors.forename: Mario E
authors.initials: ME
authors.lastname: Lacouture
mesh_terms: D017486:Acneiform Eruptions / Q000139:chemically induced; D000203:Activities of Daily Living; D000970:Antineoplastic Agents / Q000009:adverse effects*; D003873:Dermatitis, Exfoliative / Q000139:chemically induced; D004014:Dictionaries as Topic; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D006201:Hair Diseases / Q000139:chemically induced; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D010304:Paronychia / Q000139:chemically induced; D012871:Skin Diseases / Q000139:chemically induced* / Q000145:classification*; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced / Q000209:etiology; D009626:Terminology as Topic
chemical_list: D000970:Antineoplastic Agents; D066246:ErbB Receptors